Compounds > n-(2-hydroxypropyl)methacrylamide
Page last updated: 2024-08-23

n-(2-hydroxypropyl)methacrylamide and pirarubicin

n-(2-hydroxypropyl)methacrylamide has been researched along with pirarubicin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chytil, P; Etrych, T; Fang, J; Maeda, H; Nakamura, H; Ohkubo, M; Ulbrich, K1
Chytil, P; Etrych, T; Fang, J; Haratake, M; Koziolová, E; Maeda, H; Nakamura, H; Tsukigawa, K; Ulbrich, K1
Chytil, P; Etrych, T; Haratake, M; Koziolová, E; Maeda, H; Nakamura, H1
Chytil, P; Etrych, T; Fang, J; Islam, R; Mamoru, H; Nakamura, H; Randárová, E; Studenovský, M1

Other Studies

4 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and pirarubicin

ArticleYear
Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.
    Journal of controlled release : official journal of the Controlled Release Society, 2014, Jan-28, Volume: 174

    Topics: Acrylamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; HeLa Cells; Humans; Male; Mice; Neoplasms; Polymers; Tissue Distribution; Tumor Burden

2014
Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Molecular pharmaceutics, 2016, 12-05, Volume: 13, Issue:12

    Topics: Acrylamides; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Proliferation; Doxorubicin; Drug Carriers; Humans; Mice; Mice, Inbred BALB C; Polymers; Sarcoma, Experimental; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2016
Superior Penetration and Cytotoxicity of HPMA Copolymer Conjugates of Pirarubicin in Tumor Cell Spheroid.
    Molecular pharmaceutics, 2019, 08-05, Volume: 16, Issue:8

    Topics: Acrylamides; Antineoplastic Agents; Doxorubicin; Drug Carriers; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Neoplasms; Spheroids, Cellular

2019
Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.
    Acta biomaterialia, 2020, 04-01, Volume: 106

    Topics: Acrylamides; Animals; Antineoplastic Agents; Caproates; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Mice; Nanomedicine; Polymerization; Sarcoma, Experimental

2020